The cigarette smoking rate among U.S. adults dropped to another all-time low last year
Day: May 29, 2026
Pentagon failed to assess impact of cuts to civilian workforce, watchdog finds
A new Government Accountability Office (GAO) probe has found that the Pentagon failed to evaluate the…
President Trump’s face could appear on a $250 bill and the U.S. agrees to a deal with Kenya to establish an Ebola quarantine center for Americans. Read more in today’s WSJ Politics newsletter:
Plus, President Trump’s face could appear on a $250 bill and the U.S. agrees to a…
Dell shares soared in after-hours trading Thursday after the computer hardware maker reported growth in AI servers for data centers and details emerged about a $9.7 billion military contract
Shares in the computer hardware maker are up 150% since President Trump’s accounts purchased more than…
The U.S. is expected to propose a change to the USMCA agreement that would require half of the components and materials in an automobile to come from U.S. sources to qualify for lower tariffs
The pact with Mexico and Canada currently doesn’t have a U.S.-specific requirement.
A federal judge ordered the Trump administration to pause efforts to set up a $1.8 billion fund to compensate people who believe they were improperly investigated and prosecutedÂ
The order temporarily prevents officials from transferring money into or paying claims out of the $1.8…
A federal judge ruled that Trump’s name must be removed from the John F. Kennedy Center for the Performing Arts and that the institution cannot be closed while it undergoes extensive renovations
The decision also stops the president from temporarily closing the national cultural institution during renovations.
Democratic lawmakers said former AG Pam Bondi refused to answer questions about Trump during an interview with the House Oversight Committee over about the DOJ’s release of Epstein files
The former attorney general sat for an interview with lawmakers about the Justice Department’s release of…
Replimune reached an agreement with the FDA on a path to resubmit its experimental melanoma treatment for approval
Experimental melanoma drug was rejected twice because the Food and Drug Administration questioned its study design.